Nature Communications

Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives

2026-08-21

Full text

DOI https://doi.org/10.1038/s41467-026-76559-4